These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 4800933)

  • 1. Serum enzyme alterations in neuromuscular disorders.
    Munsat TL; Baloh R; Pearson CM; Fowler W
    JAMA; 1973 Dec; 226(13):1536-43. PubMed ID: 4800933
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical aspects of genetically determined progressive muscular dystrophies.
    Luca N; Haţegan D
    Rev Roum Neurol; 1973; 10(6):531-7. PubMed ID: 4771091
    [No Abstract]   [Full Text] [Related]  

  • 3. [Progressive muscle dystrophy. II. Enzyme activity chages in serum in progressive muscle dystrophy].
    Lujf A; Sluga E; Moser K
    Wien Klin Wochenschr; 1971 Feb; 83(7):109-13. PubMed ID: 5547427
    [No Abstract]   [Full Text] [Related]  

  • 4. [Enzymatic activity of the serum in the family of a progressive muscular dystrophy patient].
    Esaki K; Tokoro T; Yamamoto K; Kato T; Asano B
    Iryo; 1969 Oct; 23(10):1306-11. PubMed ID: 5364982
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of exercise on serum enzymes.
    Fowler WM; Gardner GW; Kazerunian HH; Lauvstad WA
    Arch Phys Med Rehabil; 1968 Oct; 49(10):554-65. PubMed ID: 5685050
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum enzyme studies in inherited disease of skeletal muscle.
    Thomson WH
    Clin Chim Acta; 1971 Nov; 35(1):183-91. PubMed ID: 5126991
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in the activity of blood serum enzymes in relatives of children with myopathy].
    Grinio LP
    Vopr Med Khim; 1966; 12(6):600-3. PubMed ID: 6000902
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on enzymatic activity in serum obtained from muscular dystrophic patients.
    Yamaji K; Imai H; Esaki K; Tokoro T; Hotta K
    Nagoya Med J; 1968 Apr; 14(1):55-64. PubMed ID: 5696330
    [No Abstract]   [Full Text] [Related]  

  • 9. An investigation of physical factors influencing the behaviour in vitro of serum creatine phosphokinase and other enzymes.
    Thomson WH
    Clin Chim Acta; 1969 Jan; 23(1):105-20. PubMed ID: 5762120
    [No Abstract]   [Full Text] [Related]  

  • 10. [Histological, serum enzyme and electromyographic studies in thyreomyopathies in children (research on hypothroid patients)].
    Iafusco F; Canani MB; Granata E
    Pediatria (Napoli); 1967 Dec; 75(6):893-913. PubMed ID: 5617794
    [No Abstract]   [Full Text] [Related]  

  • 11. A serum isozyme study in muscular dystrophy. Particular reference to creatine kinase, aspartate aminotransferase, and lactic acid dehydrogenase isozymes.
    Somer H; Donner M; Murros J; Konttinen A
    Arch Neurol; 1973 Nov; 29(5):343-5. PubMed ID: 4743886
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence against the existence of a subclinical form of X-linked Duchenne muscular dystrophy.
    Emery AE; Spikesman A
    J Neurol Sci; 1970 Jun; 10(6):523-33. PubMed ID: 5422556
    [No Abstract]   [Full Text] [Related]  

  • 13. [Enzymatic and morphologic correlations in tetanus].
    Agostini B; Eyrich K; Müller E; Noetzel H; Wiemers K
    Quad Sclavo Diagn; 1971 Mar; 7(1):393-405. PubMed ID: 5155196
    [No Abstract]   [Full Text] [Related]  

  • 14. [Contribution to the study of the enzymology of primary myopathies of childhood].
    Vitetta M
    Biol Lat; 1965; 18(4):359-66. PubMed ID: 5871253
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosis of occult muscular dystrophy: importance of the "chance" finding of elevated serum aminotransferase activities.
    Morse RP; Rosman NP
    J Pediatr; 1993 Feb; 122(2):254-6. PubMed ID: 8429443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of drug administration on the child with progressive muscular dystrophy].
    Nakahara T; Annaka S; Baba T; Kanno M
    Iryo; 1969 Oct; 23(10):1319-27. PubMed ID: 5364983
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum muscle-specific enolase in progressive muscular dystrophy and other neuromuscular diseases.
    Mokuno K; Riku S; Matsuoka Y; Sobue I; Kato K
    J Neurol Sci; 1984 Mar; 63(3):345-52. PubMed ID: 6726277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum enzymatic activity in neuromuscular diseases].
    Strumień M
    Neurol Neurochir Pol; 1975; 9(1):1-5. PubMed ID: 1121344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood enzymes in Duchene's progressive muscular dystrophy and their correlation with the clinical and histological pictures.
    Niebrój-Dobosz I; Jedrzejowska H; Hetnarska L
    Acta Med Pol; 1970; 11(4):387-93. PubMed ID: 5493781
    [No Abstract]   [Full Text] [Related]  

  • 20. [Contribution on the study of pseudohypertrophic muscular dystrophies. II. Pseudohypertrophic muscular dystrophies in females].
    Radu H; Stenzel K
    Dtsch Z Nervenheilkd; 1969; 196(2):116-35. PubMed ID: 5800953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.